Systemic Therapy of Cholangiocarcinoma
Ruben R Plentz1, Nisar P Malek1
1Department of Internal Medicine I, Medical University Hospital, Tübingen, Germany.
Visceral Medicine
|February 24, 2017
Summary
Current treatments for cholangiocarcinoma (CC) include gemcitabine and cisplatin chemotherapy. Research is ongoing for new therapies, including immunotherapies, to improve options for this liver cancer.
Area of Science:
- Oncology
- Hepatology
- Gastroenterology
Background:
- Cholangiocarcinoma (CC) is a prevalent primary liver cancer.
- Limited therapeutic options exist for advanced CC.
- Novel oncology treatments have shown modest impact.
Purpose of the Study:
- To review current palliative chemotherapy for CC.
- To outline emerging drug therapies for CC.
- To discuss the status of novel systemic treatments.
Main Methods:
- Literature review of current palliative chemotherapy.
- Analysis of novel drug therapies and clinical trials.
- Evaluation of targeted therapies like VEGFR and EGFR inhibitors.
Main Results:
- Gemcitabine and cisplatin are standard first-line chemotherapy for inoperable CC.
- Second-line chemotherapy lacks standardization and depends on prior treatment.
- Targeted therapies (VEGFR, EGFR antibodies) yielded mixed or negative results; new molecular treatments are not established.
Conclusions:
- Ongoing clinical trials are exploring new therapeutic strategies for CC.
- Immunotherapies represent a promising area of active investigation for CC treatment.
- Further research is needed to establish novel systemic treatments.
More Related Videos
Related Concept Videos
01:29Chronic Pancreatitis II: Collaborative Care
447
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
447
02:49Cancer Therapies
10.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.5K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K